Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in inoperable Stage III NSCLC
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.jtho.2017.09.1705
dc.identifier.other
WOS:000463860802302
dc.description.volume
dc.description.issue
Publisher
ELSEVIER SCIENCE INC
DOI
10.1016/j.jtho.2017.09.1705
